The store will not work correctly when cookies are disabled.
N-[2-(2-Hydroxy-3-phenoxy-propylamino)-ethyl]-methanesulfonamide; compound with oxalic acid
ID: ALA3392266
PubChem CID: 13030953
Max Phase: Preclinical
Molecular Formula: C14H22N2O8S
Molecular Weight: 288.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CS(=O)(=O)NCCNCC(O)COc1ccccc1.O=C(O)C(=O)O
Standard InChI: InChI=1S/C12H20N2O4S.C2H2O4/c1-19(16,17)14-8-7-13-9-11(15)10-18-12-5-3-2-4-6-12;3-1(4)2(5)6/h2-6,11,13-15H,7-10H2,1H3;(H,3,4)(H,5,6)
Standard InChI Key: NYNXZPAUZKCWQI-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 24 0 0 0 0 0 0 0 0999 V2000
5.5687 -6.6295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3937 -6.6295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8062 -7.3439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8062 -5.9150 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1562 -5.9150 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1562 -7.3439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3013 -3.4160 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.0146 -3.8332 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3013 -2.5902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5881 -3.8290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5829 -3.4035 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0146 -3.0031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0094 -3.4035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2961 -3.8164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8748 -3.4160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4484 -3.4077 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8697 -3.8081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0219 -2.5777 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7226 -3.8207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1616 -3.8290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1564 -3.3910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8697 -4.6340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4432 -3.8081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1564 -5.0427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4432 -4.6340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
1 5 2 0
1 6 1 0
8 7 2 0
9 7 2 0
10 7 1 0
11 14 1 0
12 7 1 0
13 19 1 0
14 13 1 0
15 10 1 0
16 20 1 0
17 11 1 0
18 13 1 0
19 16 1 0
20 15 1 0
21 17 1 0
22 17 2 0
23 21 2 0
24 22 1 0
25 24 2 0
25 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 288.37 | Molecular Weight (Monoisotopic): 288.1144 | AlogP: -0.43 | #Rotatable Bonds: 9 |
Polar Surface Area: 87.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.57 | CX Basic pKa: 8.32 | CX LogP: -0.66 | CX LogD: -1.63 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.54 | Np Likeness Score: -1.13 |
References
1. Lare MS, Smith LH.. (1982) Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido) alkyl]amino]-2-propanols., 25 (11): [PMID:6128420] [10.1021/jm00353a004] |